skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Products

Show More

Show More

46 Total results for product and free and sample content found

Medtech Insight

UK All-Party Report Assesses Brexit Medtech Impact While Germany Worries Over Border Delays

By Ashley Yeo 27 Jan 2021

UK All-Party Report Assesses Brexit Medtech Impact While Germany Worries Over Border Delays

Government and industry in the UK are determined to make the best of the Brexit free trade deal, but German medtechs are eager for trade flow practicalities to be prioritized.

Topic Brexit Medtech-Brexit

Medtech Insight

Brexit: Medical Supplies Facing ‘Significant Disruption’ At Ports

By Ian Schofield 27 Nov 2020

Brexit: Medical Supplies Facing ‘Significant Disruption’ At Ports

As negotiators struggle to reach agreement on the future UK/EU relationship following Brexit, suppliers have been warned to expect major hold-ups next year for medical products crossing the English Channel.

Topic EU Brexit

Pink Sheet

Brexit: UK Joining US-Led Project Orbis To Speed Cancer Drug Approvals

By Neena ​ Brizmohun 23 Nov 2020

Brexit: UK Joining US-Led Project Orbis To Speed Cancer Drug Approvals

Joining the international regulatory collaboration could become a key route for the UK to remain an early and priority market for global launches after the end of the Brexit transition period, says the industry group, BIA.

Topic Pharma-Brexit Brexit

Pink Sheet

Act Quickly On Converted EU Product Approvals GB Firms Urged

By Ian Schofield 23 Nov 2020

Act Quickly On Converted EU Product Approvals, GB Firms Urged

The UK medicines regulator has written to pharmaceutical companies outlining the actions they need to take regarding products with a centralized EU approval that will be converted to Great Britain marketing authorizations next year. 

Topic Pharma-Brexit Brexit Approvals

Pink Sheet

NICE Reform Plans Aim To Help Make Post-Brexit UK A 'First Launch' Country

By Ian Schofield 17 Nov 2020

Post brexit NICE reform plans

Following a Brexit-induced delay over the summer, England's HTA body NICE has come up with a concrete set of proposals that it says will help it “robustly and efficiently” evaluate innovative technologies such as advanced therapies, histology-independent cancer treatments, and technologies for rare diseases. Industry bodies have welcomed the plans, which have just been put out for consultation.

Topic Brexit EU

Pink Sheet

'No Turning Back' On Regulatory Changes at UK MHRA

By Ian Schofield 02 Oct 2020

Brexit Regulation

The UK medicines regulator has a “unique opportunity” to evaluate the systems it operates and to “do things differently", according to its long-term interim head, June Raine.

Topic Policy & Regulation Brexit

Generics Bulletin

Time Is Short To Prepare For New Post-Brexit UK Regulation

By David Wallace 09 Sep 2020

Time Is Short To Prepare For New Post-Brexit UK Regulation

Guidance from the UK’s MHRA on post-Brexit arrangements relevant to the off-patent industry has been welcomed by local industry body the BGMA. However, it has warned that time is short to prepare for the end of the UK-EU transition period, with new guidance in certain areas “critical.”

Topic Brexit

Medtech Insight

UK Readies Medtech And Pharma Sectors For Regulatory Life Outside The EU

By Ashley Yeo 26 Aug 2020

UK Readies Medtech And Pharma Sectors For Regulatory Life Outside The EU

Work has started on UK-only regulations for the medtech and medicines sectors, to ensure that the regulatory framework not only functions but can also react swiftly to needs after the UK leaves the EU. This article is part two of two.

Topic EU Medtech-Brexit Regulation Brexit

Pink Sheet

UK Industry Gears Up For Tough Post-Brexit Talks With EU

By Ian Schofield 26 Aug 2020

UK Industry Gears Up For Tough Post-Brexit Talks With EU

As the UK prepares to leave the EU, the life sciences industry has urged the government to seek the maximum regulatory alignment and cooperation with the EU. But time is tight, there is much to do, and the industry may struggle to get its voice heard.

Topic Regulation Brexit

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: